Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Identify and Report Methotrexate Dosing Irregularity During Pharmacy Review

Colchester, Connecticut Survey Completed on 03-26-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The deficiency involves the facility’s failure to ensure that the consulting pharmacy identified and reported a significant medication irregularity involving Methotrexate dosing for a newly admitted resident. The resident’s hospital discharge orders specified Methotrexate 2.5 mg, four tablets in the morning and three tablets in the evening, to be given once weekly. When the orders were transcribed at the facility, the Methotrexate frequency was incorrectly entered as once daily instead of once weekly, and these incorrect orders were sent electronically to the pharmacy. The pharmacy filled the Methotrexate as written on the incorrect daily orders. During the monthly drug regimen review for new admissions, the pharmacist did not identify the Methotrexate order as an irregularity, despite the EMR’s MAR dose warning indicating that the entered dose and daily frequency were outside the recommended regimen of one to ten tablets every seven days. Interviews with pharmacy personnel confirmed that two pharmacists reviewed and approved the order without recognizing the incorrect frequency, and the pharmacist in charge attributed the failure to human error. The resident had diagnoses including rheumatoid arthritis, dysphagia, metabolic encephalopathy, atrial fibrillation, and congestive heart failure, and was assessed as cognitively intact with moderate assistance needs for ADLs. Following the incorrect daily administration of Methotrexate, the resident developed thrush and later became neutropenic with altered respiratory status, as reflected in revisions to the resident’s care plan. Hospital records for a subsequent hospitalization documented admission for neutropenic fever, Methotrexate toxicity, and sepsis, during which the Methotrexate medication error was discovered. The resident required intubation and ICU care and ultimately expired after extubation.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙